{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:48:29Z","timestamp":1788011309625,"version":"build-2784847793"},"reference-count":70,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CNRS GDR 2088 \u201cBIOMIM\u201d"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The emergence and rapid evolution of human pathogenic viruses, combined with the difficulties in developing effective vaccines, underline the need to develop innovative broad-spectrum antiviral therapeutic agents. The present study aims to determine the in silico antiviral potential of six bacterial antimicrobial peptides (AMPs), two phytochemicals (silvestrol, andrographolide), and two bacterial secondary metabolites (lyngbyabellin A, hapalindole H) against dengue virus, Zika virus, Ebola virus, the major variants of SARS-CoV-2 and monkeypox virus. The comparison of docking scores obtained with natural biomolecules was performed with specific neutralizing antibodies (positive controls for ClusPro) and antiviral drugs (negative controls for Autodock Vina). Glycocin F was the only natural biomolecule tested to show high binding energies to all viral surface proteins and the corresponding viral cell receptors. Lactococcin G and plantaricin ASM1 also achieved high docking scores with all viral surface proteins and most corresponding cell surface receptors. Silvestrol, andrographolide, hapalindole H, and lyngbyabellin A showed variable docking scores depending on the viral surface proteins and cell receptors tested. Three glycocin F mutants with amino acid modifications showed an increase in their docking energy to the spike proteins of SARS-CoV-2 B.1.617.2 Indian variant, and of the SARS-CoV-2 P.1 Japan\/Brazil variant, and the dengue DENV envelope protein. All mutant AMPs indicated a frequent occurrence of valine and proline amino acid rotamers. AMPs and glycocin F in particular are the most promising biomolecules for the development of broad-spectrum antiviral treatments targeting the attachment and entry of viruses into their target cell.<\/jats:p>","DOI":"10.3390\/ijms231911131","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T05:33:14Z","timestamp":1663824794000},"page":"11131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Molecular Docking and In-Silico Analysis of Natural Biomolecules against Dengue, Ebola, Zika, SARS-CoV-2 Variants of Concern and Monkeypox Virus"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3068-4349","authenticated-orcid":false,"given":"Mackingsley Kushan","family":"Dassanayake","sequence":"first","affiliation":[{"name":"School of Pharmacy, Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, Semenyih 43500, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8966-3369","authenticated-orcid":false,"given":"Teng-Jin","family":"Khoo","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, Semenyih 43500, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0877-1515","authenticated-orcid":false,"given":"Chien Hwa","family":"Chong","sequence":"additional","affiliation":[{"name":"Department of Chemical and Environmental Engineering, Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, Semenyih 43500, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5450-2733","authenticated-orcid":false,"given":"Patrick","family":"Di Martino","sequence":"additional","affiliation":[{"name":"BCMI Research Group, ERRMECe Laboratory, Cergy Paris University, 95000 Cergy-Pontoise, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41893-019-0293-3","article-title":"Emerging human infectious diseases and the links to global food production","volume":"2","author":"Rohr","year":"2019","journal-title":"Nat. Sustain."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"631736","DOI":"10.3389\/fmicb.2020.631736","article-title":"Pandemics Throughout History","volume":"11","author":"Piret","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41564-018-0296-2","article-title":"Tracking virus outbreaks in the twenty-first century","volume":"4","author":"Grubaugh","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1016\/j.vaccine.2017.04.082","article-title":"AIDS, Avian flu, SARS, MERS, Ebola, Zika\u2026 what next?","volume":"35","author":"Reperant","year":"2017","journal-title":"Vaccine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"102364","DOI":"10.1016\/j.tmaid.2022.102364","article-title":"International outbreaks of Monkeypox virus infection with no established travel: A public health concern with significant knowledge gap","volume":"49","author":"Barry","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Shao, W., Li, X., Goraya, M.U., Wang, S., Chen, J.L., and Shao, W. (2017). Evolution of Influenza A Virus by Mutation and Re-Assortment. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081650"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3390\/v4091438","article-title":"Invasion of Influenza A Viruses from Innate and Adaptive Immune Responses","volume":"4","author":"Li","year":"2012","journal-title":"Viruses"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40794-020-00129-9","article-title":"COVID-19 in comparison with other emerging viral diseases: Risk of geographic spread via travel","volume":"7","year":"2021","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Burrell, C.J. (2017). Epidemiology of Viral Infections. Fenner and White\u2019s Medical Virology, Academic Press.","DOI":"10.1016\/B978-0-12-375156-0.00013-8"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ansah, J.P., Matchar, D.B., Shao, W.S.L., Low, J.G., Pourghaderi, A.R., Siddiqui, F.J., Min, T.L.S., Weiyan, A.C., and Ong, M.E.H. (2021). The effectiveness of public health interventions against COVID-19: Lessons from the Singapore experience. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248742"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12992-021-00677-5","article-title":"How does globalization affect COVID-19 responses?","volume":"17","author":"Bickley","year":"2021","journal-title":"Glob. Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/14787210.2019.1635009","article-title":"Broad-Spectrum Antiviral Agents: A Crucial Pandemic Tool","volume":"17","author":"Adalja","year":"2019","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e01682-20","DOI":"10.1128\/JVI.01682-20","article-title":"Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides","volume":"94","author":"Hoffmann","year":"2020","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2001433","DOI":"10.1002\/adhm.202001433","article-title":"Broad-Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity","volume":"10","author":"Zelikin","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Geraghty, R., Aliota, M., and Bonnac, L. (2021). Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. Viruses, 13.","DOI":"10.3390\/v13040667"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100721","DOI":"10.1016\/j.drup.2020.100721","article-title":"Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses","volume":"3","author":"Artese","year":"2020","journal-title":"Drug Resist. Updates"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fmicb.2013.00321","article-title":"Current scenario of peptide-based drugs: The key roles of cationic antitumor and antiviral peptides","volume":"4","author":"Mulder","year":"2013","journal-title":"Front. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ghildiyal, R., Prakash, V., Chaudhary, V.K., Gupta, V., and Gabrani, R. (2020). Phytochemicals as Antiviral Agents: Recent Updates. Plant-Derived Bioactives: Production, Properties and Therapeutic Applications, Springer.","DOI":"10.1007\/978-981-15-1761-7_12"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100515","DOI":"10.1016\/j.imu.2021.100515","article-title":"Manipulated bio antimicrobial peptides from probiotic bacteria as proposed drugs for COVID-19 disease","volume":"23","author":"Balmeh","year":"2021","journal-title":"Inform. Med. Unlocked"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Murad, F., and Atta-ur-Rahman, B.K. (2021). Infectious Diseases, Bentham Science Publishers.","DOI":"10.2174\/97898114587121200401"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Saunders-Hastings, P.R., and Krewski, D. (2016). Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission. Pathogens, 5.","DOI":"10.3390\/pathogens5040066"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.53022\/oarjbp.2021.2.1.0037","article-title":"Protein and peptide research applied to Covid-19 and SARS-CoV-2","volume":"2","year":"2021","journal-title":"Open Access Res. J. Biol. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/prot.24403","article-title":"How good is automated protein docking?","volume":"81","author":"Kozakov","year":"2013","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"ref_25","unstructured":"Schr\u00f6dinger, L., and De Lano, W. (2021, August 08). Incentive PyMOL Software Package. Available online: https:\/\/pymol.org\/2\/."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s13205-020-02578-7","article-title":"In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2","volume":"11","author":"Hiremath","year":"2021","journal-title":"3 Biotech"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"16861","DOI":"10.3390\/molecules191016861","article-title":"Ionization states, cellular toxicity and molecular modeling studies of midazolam complexed with trimethyl-\u03b2-cyclodextrin","volume":"19","author":"Shityakov","year":"2014","journal-title":"Molecules"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100096","DOI":"10.1016\/j.metop.2021.100096","article-title":"Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic","volume":"10","author":"Vallianou","year":"2021","journal-title":"Metab. Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"599568","DOI":"10.3389\/fimmu.2020.599568","article-title":"Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection","volume":"11","author":"Longet","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hickman, M.R., Saunders, D.L., Bigger, C.A., Kane, C.D., and Iversen, P.L. (2022). The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010220"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e00028-20","DOI":"10.1128\/CMR.00028-20","article-title":"Coronavirus Disease 2019\u2013COVID-19","volume":"33","author":"Dhama","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fmicb.2015.00517","article-title":"Broad-spectrum antiviral agents","volume":"6","author":"Zhu","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.1021\/acs.jmedchem.0c00606","article-title":"COVID-19: Drug Targets and Potential Treatments","volume":"63","author":"Gil","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","article-title":"Immune Response to Dengue and Zika","volume":"36","author":"ElongNgono","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Musarra-Pizzo, M., Pennisi, R., Ben-Amor, I., Mandalari, G., and Sciortino, M.T. (2021). Antiviral Activity Exerted by Natural Products against Human Viruses. Viruses, 13.","DOI":"10.3390\/v13050828"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2016.11.011","article-title":"The natural compound silvestrol is a potent inhibitor of Ebola virus replication","volume":"137","author":"Biedenkopf","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Elgner, F., Sabino, C., Basic, M., Ploen, D., Gr\u00fcnweller, A., and Hildt, E. (2018). Inhibition of Zika Virus Replication by Silvestrol. Viruses, 10.","DOI":"10.3390\/v10040149"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2018.07.010","article-title":"The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo","volume":"157","author":"Todt","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.antiviral.2017.12.010","article-title":"Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses","volume":"150","author":"Schulte","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"652335","DOI":"10.3389\/fphar.2021.652335","article-title":"Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19","volume":"12","author":"Singh","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/1389201022666210322124348","article-title":"Herbal Medicines to Fight Against COVID-19: New Battle with an Old Weapon","volume":"23","author":"Harwansh","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Henss, L., Scholz, T., Gr\u00fcnweller, A., and Schnierle, B.S. (2018). Silvestrol Inhibits Chikungunya Virus Replication. Viruses, 10.","DOI":"10.3390\/v10110592"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"105012","DOI":"10.1016\/j.antiviral.2021.105012","article-title":"The rocaglate CR-31-B (\u2212) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo","volume":"186","author":"Obermann","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_46","first-page":"1934578X2110166","article-title":"Andrographispaniculata (Burm. F.) Wall. Ex Nees, Andrographolide, and Andrographolide Analogues as SARS-CoV-2 Antivirals? A Rapid Review","volume":"16","author":"Lim","year":"2021","journal-title":"Nat. Prod. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2016.12.014","article-title":"Activity of andrographolide against dengue virus","volume":"139","author":"Panraksa","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4308\/hjb.22.2.67","article-title":"Antiviral and Immunostimulant Activities of Andrographis paniculata","volume":"22","author":"Adiguna","year":"2015","journal-title":"HAYATI J. Biosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"14179","DOI":"10.1038\/srep14179","article-title":"Activity of andrographolide against chikungunya virus infection","volume":"5","author":"Wintachai","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157340611795564268","article-title":"A Potential Andrographolide Analogue against the Replication of Herpes Simplex Virus Type 1 in Vero Cells","volume":"7","author":"Seubsasana","year":"2011","journal-title":"Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Li, F., Khanom, W., Sun, X., Paemanee, A., Roytrakul, S., Wang, D., and Smith, D.R. (2020). Andrographolide and Its 14-Aryloxy Analogues Inhibit Zika and Dengue Virus Infection. Molecules, 25.","DOI":"10.3390\/molecules25215037"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1021\/acs.jnatprod.0c01324","article-title":"Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives","volume":"84","author":"Suksatu","year":"2021","journal-title":"J. Nat. Prod."},{"key":"ref_53","first-page":"3092","article-title":"Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach","volume":"39","author":"Enmozhi","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1541-4337.2003.tb00016.x","article-title":"Bacteriocins and their Food Applications","volume":"2","author":"Chen","year":"2003","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ma\u0142aczewska, J., Kaczorek-\u0141ukowska, E., W\u00f3jcik, R., and Siwicki, A.K. (2019). Antiviral effects of nisin, lysozyme, lactoferrin and their mixtures against bovine viral diarrhoea virus. BMC Vet Res., 15.","DOI":"10.1186\/s12917-019-2067-6"},{"key":"ref_56","first-page":"052","article-title":"In vitro antiviral and antimicrobial activities of Spirulina platensis extract","volume":"3","author":"Kamel","year":"2013","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s43088-021-00138-3","article-title":"Interaction of SARS-CoV-2 spike protein with angiotensin converting enzyme inhibitors and selected compounds from the chemical entities of biological interest","volume":"10","author":"Aminu","year":"2021","journal-title":"Beni-Suef Univ. J. Basic Appl. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ddtec.2006.09.004","article-title":"New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery","volume":"3","author":"Tang","year":"2006","journal-title":"Drug Discov. Today Technol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"12374","DOI":"10.21037\/apm-21-3373","article-title":"The efficacy of probiotics in patients with severe COVID-19","volume":"10","author":"Wang","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnesp.2021.10.016","article-title":"The efficacy of probiotics on virus titres and antibody production in virus diseases: A systematic review on recent evidence for COVID-19 treatment","volume":"46","author":"Mirashrafi","year":"2021","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e00809-18","DOI":"10.1128\/JVI.00809-18","article-title":"Surfactin Inhibits Membrane Fusion during Invasion of Epithelial Cells by Enveloped Viruses","volume":"92","author":"Yuan","year":"2018","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ja.2011.21","article-title":"Cyanobacteria: An emerging source for drug discovery","volume":"64","author":"Singh","year":"2011","journal-title":"J. Antibiot."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Pagarete, A., Ramos, A.S., Puntervoll, P., Allen, M.J., and Verdelho, V. (2021). Antiviral Potential of Algal Metabolites\u2014A Comprehensive Review. Mar. Drugs, 19.","DOI":"10.3390\/md19020094"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.str.2020.06.006","article-title":"Performance and Its Limits in Rigid Body Protein-Protein Docking","volume":"28","author":"Desta","year":"2020","journal-title":"Structure"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/prot.25219","article-title":"New additions to the ClusPro server motivated by CAPRI","volume":"85","author":"Vajda","year":"2017","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s40203-021-00103-z","article-title":"In-silico study of peptide-protein interaction of antimicrobial peptides potentially targeting SARS and SARS-CoV-2 nucleocapsid protein","volume":"9","author":"Bansal","year":"2021","journal-title":"In Silico Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"W96","DOI":"10.1093\/nar\/gkh354","article-title":"ClusPro: A fully automated algorithm for protein-protein docking","volume":"32","author":"Comeau","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1038\/s41598-018-23982-3","article-title":"Protein docking refinement by convex underestimation in the low-dimensional subspace of encounter complexes","volume":"8","author":"Zarbafian","year":"2018","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/19\/11131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:37:13Z","timestamp":1760143033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/19\/11131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":70,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["ijms231911131"],"URL":"https:\/\/doi.org\/10.3390\/ijms231911131","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]}}}